Tian Wang

Tian Wang

Auto-generated profile, based on publicly available information

Tian Wang

Department of Chemistry, Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology Tsinghua University Beijing 100084 P. R. China

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
JWJingjing Wang
Jingjing Wang
MWMeng Wu
Meng Wu
ZCZhangcheng Chen
Zhangcheng Chen
LWLijie Wu
Lijie Wu
TWTian Wang
Tian Wang
THTian Hua
Tian Hua
Muscarinic acetylcholine receptors (mAChRs) respond to the neurotransmitter acetylcholine and play important roles in human nervous system. Muscarinic receptor 4 (M4R) is a promising drug target for treating neurological and mental disorders, such as Alzheimer’s disease and schizophrenia. However, the lack of understanding on M4R’s activation by subtype selective agonists hinders its therapeutic applications. Here, we report the structural characterization of M4R selective allosteric agonist, compound-110, as well as agonist iperoxo and positive allosteric modulator LY2119620. Our cryo-electron microscopy structures of compound-110, iperoxo or iperoxo-LY2119620 bound M4R-Gi complex reveal their different interaction modes and activation mechanisms of M4R, and the M4R-ip-LY-Gi structure validates the cooperativity between iperoxo and LY2119620 on M4R. Through the comparative structural and pharmacological analysis, compound-110 mostly occupies the allosteric binding pocket with vertical binding pose. Such a binding and activation mode facilitates its allostersic selectivity and agonist profile. In addition, in our schizophrenia-mimic mouse model study, compound-110 shows antipsychotic activity with low extrapyramidal side effects. Thus, this study provides structural insights to develop next-generation antipsychotic drugs selectively targeting on mAChRs subtypes.

29 August 2022 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
TWTian Wang
Tian Wang
CLChuntong Li
Chuntong Li
MWMeijing Wang
Meijing Wang
JZJiachen Zhang
Jiachen Zhang
QZQingyun Zheng
Qingyun Zheng
Jinghong LiJinghong Li
Jinghong Li

1 February 2008 in Key Engineering Materials
Verified
Journal Article
Closed access
PDF file
GYGang Yang
Gang Yang
ZDZhen Yue Dr
Zhen Yue Dr
XLXiang Li
Xiang Li
TWTian Wang
Tian Wang
LLLong Li
Long Li
(1-X)BaTiO3-XCaCu2.94Mn0.06Ti4O12 (BTO-CCMTO) composite ceramics with X =0.1 and 0.2 were prepared through solid state reaction route. X-ray diffraction (XRD) analyses showed that a co-existence structure of BTO and CCMTO phase can be realized when the sample was sintered at 950°C. Furthermore, influences of CCMTO on the dielectric behaviors of the BTO-CCMTO composite ceramics were investigated. The results showed that the dielectric permittivity of the BTO-CCMTO composite ceramics increases with increasing amounts of CCMTO and the Curie peak of the pure BTO ceramics is greatly suppressed due to the addition of CCMTO. The dielectric loss of the BTO-CCMTO composite ceramics can be kept in the same magnitude order as that of the BTO ceramics.

29 August 2022 in Angewandte Chemie
Verified
Journal Article
Closed access
TWTian Wang
Tian Wang
CLChuntong Li
Chuntong Li
MWMeijing Wang
Meijing Wang
JZJiachen Zhang
Jiachen Zhang
QZQingyun Zheng
Qingyun Zheng
Jinghong LiJinghong Li
Jinghong Li

27 April 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
MAMaria Almeida
Maria Almeida
TWTian Wang
Tian Wang
ALAndrew P. Longhini
Andrew P. Longhini
SLSamuel Lobo
Samuel Lobo
CCCarolina Maciel Camargo
Carolina Maciel Camargo
DCDaniel C. Carrettiero
Daniel C. Carrettiero
Protein aggregation, impaired degradation, and immune activation are central hallmarks of neurodegenerative diseases, yet how these processes are coordinated remains unclear. Here, we identify Immune-Protein Degradation Bodies (I-PDBs), a previously unrecognized class of BAG2-driven, phase-separated organelles that integrate protein quality control with adaptive immunity. IFN-gamma; induce I-PDB formation at the endoplasmic reticulum (ER), where they concentrate immunoproteasome components, MHC-I peptide-loading machinery, and ER-associated chaperones. I-PDBs redirect proteostatic cargo from centrosomal aggregation pathways to spatially restricted degradation sites optimized for antigenic peptide generation, coupling selective substrate clearance to CD8+ T cell engagement. Using a cellular model of aggregation-prone tau, we show that I-PDBs capture pathological tau fibrils at ER-microtubule interfaces and process them into potentially antigenic peptides, thus reducing the load of aggregation-prone tau peptides. We term this mechanism the Proteostasis-Associated Immune Relay (PAIR), establishing I-PDBs as critical hubs linking proteostasis to immune surveillance with broad implications for disease.

21 September 2026 in Research Square
Verified
Preprint
Open access
PDF file
JSJudith Steen
Judith Steen
PBPieter Beerepoot
Pieter Beerepoot
LCLong Cheng
Long Cheng
MVMichael Vigers
Michael Vigers
JRJennifer Rauch
Jennifer Rauch
CUCeren Uncu
Ceren Uncu
Neuroinflammation and tau aggregation are hallmarks of Alzheimer’s disease (AD), yet the mechanistic link between them remains unknown. Analyzing a cohort of 46 AD and 40 control subjects using mass spectrometry-based proteomics, we identified a strong correlation between upregulation of the cytokine-induced antigen-presentation pathway and site-specific tau cleavage. This cleavage enriches the microtubule-binding repeat (MTBR) domain in AD tau aggregates; furthermore, synthetic MTBR fragments recapitulate tau aggregation both in vitro and in vivo. Our data show that the immunoproteasome (IP) colocalizes with tau aggregates in human AD neurons and drives the observed cleavage pattern. Proinflammatory cytokines reproduced AD-like tau cleavage and puncta formation in HEK293T cells expressing 0N4R tau, the hTau knock-in mouse, and human iPSC-derived neurons (iNeurons). IP knockdown via siRNA reduced tau-positive inclusion and upstream JAK/STAT pathway inhibition across model systems, including iNeurons, effectively abrogated cleavage and tau aggregation. These findings identify an inflammation-responsive pathway that promotes tau pathology and provide a mechanistic framework and potential therapeutic entry point for AD and potentially other tauopathies.